Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
Richard JC, Terzi N, Yonis H, Chorfa F, Wallet F, Dupuis C, Argaud L, Delannoy B, Thiery G, Pommier C, Abraham P, Muller M, Sigaud F, Rigault G, Joffredo E, Mezidi M, Souweine B, Baboi L, Serrier H, Rabilloud M, Bitker L; VT4COVID collaborators.
Richard JC, et al.
Lancet Respir Med. 2023 Nov;11(11):991-1002. doi: 10.1016/S2213-2600(23)00221-7. Epub 2023 Jul 12.
Lancet Respir Med. 2023.
PMID: 37453445
Clinical Trial.